Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...

Basic science researchers at the Johns Hopkins University School of Medicine are advancing heart health research by finding ...

or the body does not use insulin effectively. As a result, the increased levels of glucose stay in the bloodstream. Read more about how insulin and glucagon regulate blood sugar. Most research has ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

Intercontinental Exchange and RELX are among the stocks that are now expensive. We sell different types of products and services to both investment professionals and individual investors. These ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...